Counteraction by stable gastric pentadecapeptide BPC 157
15: Sikiric P, Sever M, Krezic I, Vranes H, Kalogjera L, Smoday IM, Vukovic V, Oroz K, Coric L, Skoro M, Kavelj I, Zubcic S, Sikiric S, Beketic Oreskovic L, Oreskovic I, Blagaic V, Brcic K, Strbe S, Staresinic M, Boban Blagaic A, Skrtic A, Seiwerth S
Browse our selection of anti-estrogen products above
The blood-vessel signaling associated with GHK-Cu, BPC-157, and TB-4 creates a theoretical concern, not a measured human tumor risk
FDA Regulatory Status The FDAs position is unambiguous: BPC-157 is not an approved drug for any medical condition